ICD-10-CM Code Q81.2

Epidermolysis bullosa dystrophica

Version 2020 Billable Code POA Exempt

Valid for Submission

Q81.2 is a billable code used to specify a medical diagnosis of epidermolysis bullosa dystrophica. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code Q81.2 might also be used to specify conditions or terms like acral dystrophic epidermolysis bullosa, centripetalis recessive dystrophic epidermolysis bullosa, dominant dystrophic epidermolysis bullosa, dominant dystrophic epidermolysis bullosa with absence of skin, dominant dystrophic epidermolysis bullosa, albopapular type, dystrophic epidermolysis bullosa, etc The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.

ICD-10:Q81.2
Short Description:Epidermolysis bullosa dystrophica
Long Description:Epidermolysis bullosa dystrophica

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code Q81.2 are found in the index:


Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Acral dystrophic epidermolysis bullosa
  • Centripetalis recessive dystrophic epidermolysis bullosa
  • Dominant dystrophic epidermolysis bullosa
  • Dominant dystrophic epidermolysis bullosa with absence of skin
  • Dominant dystrophic epidermolysis bullosa, albopapular type
  • Dystrophic epidermolysis bullosa
  • Dystrophic epidermolysis bullosa inverse type
  • Dystrophic epidermolysis bullosa nails only
  • Generalized dystrophic epidermolysis bullosa
  • Generalized recessive dystrophic epidermolysis bullosa mitis
  • Generalized recessive non-mutilating dystrophic epidermolysis bullosa
  • Localized dystrophic epidermolysis bullosa
  • Localized recessive dystrophic epidermolysis bullosa
  • Progressive recessive dystrophic epidermolysis bullosa
  • Recessive dystrophic epidermolysis bullosa
  • Recessive dystrophic epidermolysis bullosa non-Hallopeau Siemens type
  • Severe generalized recessive dystrophic epidermolysis bullosa

Clinical Information

  • EPIDERMOLYSIS BULLOSA DYSTROPHICA-. form of epidermolysis bullosa characterized by atrophy of blistered areas severe scarring and nail changes. it is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms. all forms of dystrophic epidermolysis bullosa result from mutations in collagen type vii a major component fibrils of basement membrane and epidermis.

Diagnostic Related Groups

The ICD-10 code Q81.2 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2019 through 09/30/2020.

  • 606 - MINOR SKIN DISORDERS WITH MCC
  • 607 - MINOR SKIN DISORDERS WITHOUT MCC

Present on Admission (POA)

Q81.2 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here .

CMS POA Indicator Options and Definitions
POA Indicator CodePOA Reason for CodeCMS will pay the CC/MCC DRG?
YDiagnosis was present at time of inpatient admission.YES
NDiagnosis was not present at time of inpatient admission.NO
UDocumentation insufficient to determine if the condition was present at the time of inpatient admission.NO
WClinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.YES
1Unreported/Not used - Exempt from POA reporting. NO

Convert Q81.2 to ICD-9

  • 757.39 - Skin anomaly NEC (Approximate Flag)

Code Classification

  • Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
    • Other congenital malformations (Q80-Q89)
      • Epidermolysis bullosa (Q81)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Information for Patients


Skin Conditions

Your skin is your body's largest organ. It covers and protects your body. Your skin

  • Holds body fluids in, preventing dehydration
  • Keeps harmful microbes out, preventing infections
  • Helps you feel things like heat, cold, and pain
  • Keeps your body temperature even
  • Makes vitamin D when the sun shines on it

Anything that irritates, clogs, or inflames your skin can cause symptoms such as redness, swelling, burning, and itching. Allergies, irritants, your genetic makeup, and certain diseases and immune system problems can cause rashes, hives, and other skin conditions. Many skin problems, such as acne, also affect your appearance.

NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases


[Learn More]

Dystrophic epidermolysis bullosa Epidermolysis bullosa is a group of genetic conditions that cause the skin to be very fragile and to blister easily. Blisters and skin erosions form in response to minor injury or friction, such as rubbing or scratching. Dystrophic epidermolysis bullosa (DEB) is one of the major forms of epidermolysis bullosa. The signs and symptoms of this condition vary widely among affected individuals. In mild cases, blistering may primarily affect the hands, feet, knees, and elbows. Severe cases of this condition involve widespread blistering that can lead to vision loss, disfigurement, and other serious medical problems.Researchers classify dystrophic epidermolysis bullosa into three major types. Although the types differ in severity, their features overlap significantly and they are caused by mutations in the same gene.Autosomal recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens type (RDEB-HS) is the most severe, classic form of the condition. Affected infants are typically born with widespread blistering and areas of missing skin, often caused by trauma during birth. Most often, blisters are present over the whole body and affect mucous membranes such as the moist lining of the mouth and digestive tract. As the blisters heal, they result in severe scarring. Scarring in the mouth and esophagus can make it difficult to chew and swallow food, leading to chronic malnutrition and slow growth. Additional complications of progressive scarring can include fusion of the fingers and toes, loss of fingernails and toenails, joint deformities (contractures) that restrict movement, and eye inflammation leading to vision loss. Additionally, young adults with the classic form of dystrophic epidermolysis bullosa have a very high risk of developing a form of skin cancer called squamous cell carcinoma, which tends to be unusually aggressive and is often life-threatening.A second type of autosomal recessive dystrophic epidermolysis bullosa is known as the non-Hallopeau-Siemens type (non-HS RDEB). This form of the condition is somewhat less severe than the classic type and includes a range of subtypes. Blistering is limited to the hands, feet, knees, and elbows in mild cases, but may be widespread in more severe cases. Affected people often have malformed fingernails and toenails. Non-HS RDEB involves scarring in the areas where blisters occur, but this form of the condition does not cause the severe scarring characteristic of the classic type.The third major type of dystrophic epidermolysis bullosa is known as the autosomal dominant type (DDEB). The signs and symptoms of this condition tend to be milder than those of the autosomal recessive forms, with blistering often limited to the hands, feet, knees, and elbows. The blisters heal with scarring, but it is less severe. Most affected people have malformed fingernails and toenails, and the nails may be lost over time. In the mildest cases, abnormal nails are the only sign of the condition.
[Learn More]